| Identification | Back Directory | [Name]
4-(2-chloro-4-Methoxy-5-Methyl-phenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-Methyl-phenyl)ethyl]-5-Methyl-N-prop-2-ynyl-1,3-thiazol-2-aMine | [CAS]
752253-39-7 | [Synonyms]
SSR 125543
2-Thiazolamine, 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-2-propyn-1-yl-
4-(2-chloro-4-Methoxy-5-Methyl-phenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-Methyl-phenyl)ethyl]-5-Methyl-N-prop-2-ynyl-1,3-thiazol-2-aMine | [Molecular Formula]
C27H28ClFN2OS | [MDL Number]
MFCD07772351 | [MOL File]
752253-39-7.mol | [Molecular Weight]
483.04 |
| Hazard Information | Back Directory | [Uses]
Crinecerfont (SSR-125543) hydrochloride is a potent, orally active, non-peptide CRF1 receptor antagonist. Crinecerfont can be used for Classic congenital adrenal hyperplasia (CAH) research[1]. Crinecerfont is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | [Definition]
ChEBI: SSR 125543 is an amine. | [References]
[1] Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtalyst). |
|
|